Island Pharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
David Foster
Chief executive officer
AU$350.9k
Total compensation
CEO salary percentage | 83.1% |
CEO tenure | 4.1yrs |
CEO ownership | 3.7% |
Management average tenure | no data |
Board average tenure | 2.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | AU$351k | AU$292k | -AU$3m |
Mar 31 2024 | n/a | n/a | -AU$3m |
Dec 31 2023 | n/a | n/a | -AU$2m |
Sep 30 2023 | n/a | n/a | -AU$3m |
Jun 30 2023 | AU$335k | AU$281k | -AU$3m |
Mar 31 2023 | n/a | n/a | -AU$3m |
Dec 31 2022 | n/a | n/a | -AU$3m |
Sep 30 2022 | n/a | n/a | -AU$3m |
Jun 30 2022 | AU$290k | AU$254k | -AU$3m |
Mar 31 2022 | n/a | n/a | -AU$3m |
Dec 31 2021 | n/a | n/a | -AU$3m |
Sep 30 2021 | n/a | n/a | -AU$3m |
Jun 30 2021 | AU$86k | AU$78k | -AU$2m |
Compensation vs Market: David's total compensation ($USD227.77K) is about average for companies of similar size in the Australian market ($USD297.98K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Foster
4.1yrs
Tenure
AU$350,927
Compensation
Dr. David Charles Foster also known as PhD, JD , MAICD, is Managing Director, Chief Executive Officer and President of Island Pharmaceuticals Limited and serves as its Director since October 1, 2020. Dr Fo...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD, CEO | 4.1yrs | AU$350.93k | 3.74% A$ 960.9k | |
Non-Executive Director | 4.1yrs | AU$45.00k | no data | |
Chairman of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
Independent Non-Executive Director | less than a year | no data | no data | |
Director | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
2.3yrs
Average Tenure
Experienced Board: ILA's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.